50 YEARS OF PHARMACY IN EUROPEWITH PGEU

THE COUNTIRESTHE PEOPLE

THE PROGRESS

Pages

1 Table of contents2 PGEU Brussels,3 Exposition photos4 Exposition purpose5 Belgium 19596 France 19597 Italy 19598 Germany 19599 Netherlands 195910 Greece 196011 Austria 196412 Ireland 196413 Norway 196414 Spain 196415 Sweden 196416 UK 196417 Denmark 197318 Portugal 197519 Finland 197920 Cyprus 199621 Poland 199622 Slovenia 199623 Czech 199724 Slovakia 199725 Latvia 200026 Turku 200127 Bulgaria 2004282930

The PGEU Secretariat Rue du Luxembourg 19-21,

1000 Brussels, Belgiumtelephone - +32 (0) 2 238 0818

fax - +32 (0) 2 238 0819 pharmacy@pgeu.eu

table of contents

Names of staff members and their positions and contribution to the project/exposition

Names of staff members and their po-sitions and contribution to the project/exposition

The people of PGEU Brussels

were happy to bring the exposition alive and honour all its member countries for their contribution to the bettering

of pharmacy in the European Union

for the past 50 years

The exposition night was a great success with people from all over the European Union gathering to celbrate

50 years of pharmacy.

The program included keynite speaker and head of the PGEU, SSSSSSS, fol-lowed by HHHHHHHHHHHHHH. Each banner

contained text submitted by each member country participating explaining what they found to be of historical importance to their countries pharmacy; Each

countries’ banner was unique to its cultural and exemplary to their thinking and progress.

The 26 participating countries banners were standing the European Parliment in Brussels for the week of XXX to XXX. With thise banners exstensive pamphlet

based information was provided on health and pharmacy and pharmacists were standing by to take blood pressure and answer any questions.In the next pages are all the countrue’s banners for all to read.

Congratulations to all who participated.

Belgium was a founder member of PGEU in 1959

For the last 50 years, Belgian pharmacists are continuously adding extra layers of confi dence to the quality of the products they dispense.

Historically, the Pharmaceutical Practice Law of 1885 introduced the principle of “NO FAULT responsibility”, meaning that the pharmacist has fi nal responsibility for every product (s)he dispenses.

Milestones have been set out to prevent patients being confronted to sub-standard medicine :

[1949] ORDRE DES PHARMACIENS Created to decommercialise the profession. Introduction of a continually updated Deontology Code applicable to all practicing pharmacists, to serve

the patients interests and public health: Article 1(2) The pharmacist is at the service of Public Health. He practices his activity on the patient’s interest.

Through out his entire career he must be competent and committed. Article 6 He dispenses but high quality pharmaceutical care and health products. Article 17 The pharmacist seeks to serve the patient’s interest by putting his competence and commitment to the

service of all individuals without any form of discrimination. Article 36 When dispensing, and if needed, the pharmacist clearly informs the patient about how the medicine

works, its contra-indications, side effects, interactions, possible precautionary measures, doses and how to take it, without, at the same time, undermining the patient’s confi dence on the medicine. Article 40 He must oppose to over-consumption in case of self-medication, alert the patient to its negative consequences and advise him to consult a doctor.

[1952] MEDICINES CONTROL LAB (MCL) Start-up to combat post-war fraud of penicillin-containing pharmaceuticals Independent Quality Control Laboratory, operated by APB (Association of Pharmacists in Belgium) in conjunction with the Drug Regulatory Agency of the Ministry of Health

Financed by all Belgian pharmacies through a contribution per pack Staff : ± 55 (pharmacists & lab technicians) ISO 17025 accredited Systematic re-analysis of all registered medicines, sampled at wholesaler level In case of non-conformity : centralized recall procedure, owned by MCL

[1953] QUALITY LABEL FOR PARAPHARMACEUTICALS Quality Label for cosmetics, food supplements, plant preparations, medical devices, etc. Producer has to apply for a Label, and submits all relevant information on production, formulation, stability, safety, analysis, clinical evidence, etc. Application is studied by independent commission If LABEL is granted, the product is periodically analysed by MCL The European Commission approved the Label agreement

[2006] AUTHENTICATION SYSTEM TO COMBAT COUTERFEITING Belgian Healthcare Authorities introduced a Unique Barcode per package of reimbursed pharmaceuticals to combat healthcare insurance fraud (2004) APB and Aegate collaborate to use existing mass serialisation to combat counterfeiting of medicines First launch worldwide of an authentication system at the point of dispensing – using secure technology Logical extension of APB’s efforts relating to quality assurance of pharmaceuticals and to patient safety A system to provide patient safety, allowing pharmacists to authenticate products at the moment of dispensing to the patient No interference with the work fl ow, fully integrated in the existing software, extremely fast (internet) response time. The system will generate warnings or special messages in real-time in case of products that are: • counterfeit • recalled • stolen • expired • about to be discontinued Effectiveness was confi rmed by an independent audit by the Katholieke Universiteit Leuven (2008)

CONCLUSIONFor over 50 years, Belgian pharmacists are developing and implementing rigorous and state-of-the-art measures to guarantee that their patients receive medicines of unquestionable quality.

Belgian patients protected by their

pharmacist: a unique approach on

quality assurance

www.pgeu.eu